Author:
Pan Qiang,Yang Xue-jun,Wang Hua-min,Dong Xue-tao,Wang Wei,LI Yu,LI Jing-min
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference26 articles.
1. Ohgaki, H., & Kleihues, P. (2005). Epidemiology and etiology of gliomas. Acta Neuropathologica, 109, 93–108. doi: 10.1007/s00401-005-0991-y .
2. Palanichamy, K., Erkkinen, M., & Chakravarti, A. (2006). Predictive and prognostic markers in human glioblastomas. Current Treatment Options in Oncology, 7, 490–504.
3. Grauer, O. M., Wesseling, P., & Adema, G. J. (2009). Immunotherapy of diffuse gliomas: Biological background, current status and future developments. Brain Pathology, 19, 674–693. doi: 10.1111/j.1750-3639.2009.00315.x .
4. Gao, S., Yang, X. J., Zhang, W. G., et al. (2009). Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Chinese Medical Journal (English Edition), 122, 1260–1266.
5. Ma, J., Murphy, M., O’Dwyer, P. J., et al. (2002). Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical Pharmacology, 63, 1219–1228.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献